Combination of multiplex PCR and DHPLC-based strategy for CYP2D6 genotyping scheme in Thais

Clinical Biochemistry

Volumn 44, Issue 13, 2011, Pages 1144-1152

  Suwannasri, Payiarat ^a   Thongnoppakhun, Wanna ^b   Pramyothin, Pornpen ^a   Assawamakin, Anunchai ^c   Limwongse, Chanin ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

Author keywords

CYP2D6; Denaturing high performance liquid chromatography; Multiplex PCR; Mutiplex long PCR; Single base extension

Indexed keywords

CYTOCHROME P450 2D6;

ACCURACY; ALLELE; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; COPY NUMBER VARIATION; COST EFFECTIVENESS ANALYSIS; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; FEMALE; GENE DOSAGE; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; THAILAND;

ASIAN CONTINENTAL ANCESTRY GROUP; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COST-BENEFIT ANALYSIS; CYTOCHROME P-450 CYP2D6; GENE DOSAGE; GENOTYPE; HUMANS; METHODS; MULTIPLEX POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; THAILAND;

EID: 80051680141     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.06.985     Document Type: Article

References (32)

1. Bradford D.L. CYP2D6 allele frequency in European, Caucasians, Asians, African and their descendants. Pharmacogenomics 2002, 3:229-243.
2. Dahl M.L., Yue Q.Y., Roh H.K., Johansson I., Sawe J., Sjoqvist F., et al. Genetic analysis of the CYP2D locus in relation to debrisoquine hydroxylation capacity in Korean, Japanese and Chinese subjects. Pharmacogenetics 1995, 5:159-164.
3. Griese E., Zanger U.M., Brudermanns U., Gaedigk A., Mikus G., Morike K., et al. Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German population. Pharmacogenetics 1998, 8:15-26.
4. Johansson I.O.M., Yue Q.Y., Bertilsson L., Sjoqvist F., Ingelman-Sundberg M. Genetic analysis of the Chinese cytochrome P450 locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation. Mol Pharmacol 1994, 45:452-459.
5. Bertilsson L., Dahl M.L., Dalén P., Al-Shurbaji A. Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs. Br J Clin Pharmacol 2002, 53:111-122.
6. Steen V., Andreassen O.A., Daly A.K., Tefre T., Borresen A.L., Idle J.R., et al. Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technology. Pharmacogenetics 1995, 5:215-223.
7. Daly A.K., Brockmoller J., Broly F., Eichelbaum M., Evans W.E., Gonzalez F.J., et al. Nomenclature for human CYP2D6 alleles. Pharmacogenetics 1996, 6:193-201.
8. *5 allele. Drug Metab Pharmacokinet 2005, 20:345-350.
9. Qin S., Shen L., Zhang A., Xie J., Shen W., Chen L., et al. Systematic polymorphism analysis of the CYP2D6 gene in four different geographical Han populations in mainland China. Genomics 2008, 92:152-158.
10. Johansson I., Lundqvist E., Bertilsson L., Dahl M.L., Sjoqvist F., Ingelman-Sundberg M. Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine. Proc Natl Acad Sci U S A 1993, 90:11825-11829.
11. *10 haplotype in the Japanese population. Drug Metab Pharmacokinet 2006, 21:208-216.
12. *36 with poor metabolizer status. Drug Metab Dispos 2006, 34:563-569.
13. *5 and duplication alleles when hair roots are used as a source of DNA. Clin Chim Acta 2003, 329:61-68.
14. Nevilie M., Selzer R., Aizenstein B., Maquire M., Hogan K., Walton R., et al. Characterization of cytochrome P450 2D6 alleles using the Invader system. Biotechniques 2002, 40-43. (suppl).
15. Schaeffeler E., Schwab M., Eichelbaum M., Zanger U.M. CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-time PCR. Hum Mutat 2003, 22:476-485.
16. Fuselli S., Dupanloup I., Frigato E., Cruciani F., Scozzari R., Moral P., et al. Molecular diversity at the CYP2D6 locus in the Mediterranean region. Eur J Hum Genet 2004, 12:916-924.
17. Söderbäck E., Zackrisson A.L., Lindblom B., Alderborn A. Determination of CYP2D6 gene copy number by pyrosequencing. Clin Chem 2005, 51:522-531.
18. Heller T., Kirchheiner J., Armstrong V.W., Luthe H., Tzvetkov M., Brockmöller J., et al. AmpliChip CYP450 GeneChip: a new gene chip that allows rapid and accurate CYP2D6 genotyping. Ther Drug Monit 2006, 28:673-677.
19. Hosono N., Kato M., Kiyotani K., Mushiroda T., Takata S., Sato H., et al. CYP2D6 genotyping for functional-gene dosage analysis by allele copy number detection. Clin Chem 2009, 55:1546-1554.
20. Dehainault C., Laugé A., Caux-Moncoutier V., Pagés-Berhouet S., Doz F., Desjardins L., et al. Multiplex PCR/liquid chromatography assay for detection of gene rearrangements: application to RB1 gene. Nucleic Acids Res 2004, 11(32(18)):e139.
21. Hung C.C., Su Y.N., Lin C.Y., Yang C.C., Lee W.T., Chien S.C., et al. Denaturing HPLC coupled with multiplex PCR for rapid detection of large deletions in Duchenne muscular dystrophy carriers. Clin Chem 2005, 51(7):1252-1256.
22. Yip S.P., Pun S.F., Leung K.H., Lee S.Y. Rapid simultaneous genotyping of five common Southeast Asian beta-thalassemia mutations by multiplex minisequencing and denaturing HPLC. Clin Chem 2003, 49(10):1656-1659.
23. Wu G., Hua L., Zhu J., Mo Q.H., Xu X.M. Rapid accurate genotyping of beta-thalassemia mutations using a novel multiplex primer extension/denaturing high-performance liquid chromatography assay. Br J Haematol 2003, 122(20):311-316.
24. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure of extracting DNA from human nucleated cell. Nucleic Acid Res 1988, 16(3):1215-1219.
25. Gaedigk A., Ndjountché L., Divakaran K., Dianne Bradford L., Zineh I., Oberlander T.F., et al. Cytochrome P4502D6 (CYP2D6) gene locus heterogeneity: characterization of gene duplication events. Clin Pharmacol Ther 2007, 81:242-251.
26. Wattanasirichaigoon D., Limwongse C., Jariengprasert C., Yenchitsomanus P.T., Tocharoenthanaphol C., Thongnoppakhun W., et al. High prevalence of V37I genetic variant in the connexin-26 (GJB2) gene among non-syndromic hearing-impaired and control Thai individuals. Clin Genet 2004, 66:452-460.
27. Kim E.-Y., Lee S.-S., Jung H.-J., Ung H.-E., Yeo C.-W., Shon J.-H., et al. Robust CYP2D6 genotype assay including copy number variation using multiplex single base extension for Asian populations. Clin Chim Acta 2010, 411:2043-2048.
28. Sheng H.H., Zeng A.P., Zhu W.X., Zhu R.F., Li H.M., Zhu Z.D., et al. Allelic distributions of CYP2D6 gene copy number variation in the Eastern Han Chinese population. Acta Pharmacol Sin 2007, 28:279-286.
29. *36×2 found in a Japanese poor metabolizer of debrisoquine. Pharmacogenetics 2002, 12:659-662.
30. Teh L.K., Ismail R., Yusoff R., Hussein A., Isa M.N., Rahman A.R. Heterogeneity of the CYP2D6 gene among Malays in Malaysian. J Clin Pharmacol Ther 2001, 26:205-211.
31. Gaedigk A., Coetsee C. The CYP2D6 gene locus in South African coloureds: unique allele distributions, novel alleles and gene arrangements. Eur J Clin Pharmacol 2008, 64:465-475.
32. Ledesma M.C., Agúndez J.A. Identification of subtypes of CYP2D gene rearrangements among carriers of CYP2D6 gene deletion and duplication. Clin Chem 2005, 51:939-943.